Nova Leap Health Corp. provides home and home health care services. More Details
Adequate balance sheet and fair value.
Share Price & News
How has Nova Leap Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NVLP.F has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: Insufficient data to determine how NVLP.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how NVLP.F performed against the US Market.
Price Volatility Vs. Market
How volatile is Nova Leap Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Nova Leap Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NVLP.F ($0.25) is trading below our estimate of fair value ($3.22)
Significantly Below Fair Value: NVLP.F is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: NVLP.F is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: NVLP.F is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate NVLP.F's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: NVLP.F is good value based on its PB Ratio (2.4x) compared to the US Healthcare industry average (2.8x).
How is Nova Leap Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nova Leap Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Nova Leap Health is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Nova Leap Health's filings and announcementshere.
- Explore growth companies in the Healthcare industry.
How has Nova Leap Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NVLP.F is currently unprofitable.
Growing Profit Margin: NVLP.F is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NVLP.F is unprofitable, and losses have increased over the past 5 years at a rate of 5.7% per year.
Accelerating Growth: Unable to compare NVLP.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NVLP.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).
Return on Equity
High ROE: NVLP.F has a negative Return on Equity (-10.61%), as it is currently unprofitable.
How is Nova Leap Health's financial position?
Financial Position Analysis
Short Term Liabilities: NVLP.F's short term assets ($4.5M) exceed its short term liabilities ($4.1M).
Long Term Liabilities: NVLP.F's short term assets ($4.5M) exceed its long term liabilities ($2.7M).
Debt to Equity History and Analysis
Debt Level: NVLP.F's debt to equity ratio (68.5%) is considered high.
Reducing Debt: Insufficient data to determine if NVLP.F's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable NVLP.F has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: NVLP.F is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 49.3% per year.
What is Nova Leap Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NVLP.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NVLP.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NVLP.F's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NVLP.F's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NVLP.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Chris Dobbin (45 yo)
Mr. Christopher Donald Dobbin, also known as Chris, CPA, CA, serves as the Chief Executive Officer and President of Nova Leap Health Corp. and served as its Chief Financial Officer until October 2016. Mr. ...
CEO Compensation Analysis
Compensation vs Market: Chris's total compensation ($USD175.35K) is below average for companies of similar size in the US market ($USD603.09K).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
|CEO, President & Director||no data||US$305.00k||11.56% |
|Independent Director||4.83yrs||US$23.00k||2.57% |
|Independent Chairman of the Board||no data||US$36.00k||4.26% |
|Independent Director||3yrs||US$18.00k||1.78% |
Experienced Board: NVLP.F's board of directors are considered experienced (4.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.4%.
Nova Leap Health Corp.'s company bio, employee growth, exchange listings and data sources
- Name: Nova Leap Health Corp.
- Ticker: NVLP.F
- Exchange: OTCPK
- Founded: 2015
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: CA$23.595m
- Listing Market Cap: CA$17.595m
- Shares outstanding: 65.54m
- Website: https://novaleaphealth.com
- Nova Leap Health Corp.
- 7071 Bayers Road
- Suite 5003
- Nova Scotia
- B3L 2C2
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NLH||TSXV (TSX Venture Exchange)||Yes||Common Shares||CA||CAD||Apr 2016|
|NVLP.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Apr 2016|
Nova Leap Health Corp. provides home and home health care services. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, light housekeeping, transport ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/27 05:47|
|End of Day Share Price||2020/09/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.